title: Hitting the target with antithrombotic therapy.
abstract: Thrombus treatment and prevention can be regulated by a number of intravenous or subcutaneous drugs, as well as oral warfarin. Many therapies require laboratory monitoring for efficacy and for detection of dangerous sequelae, such as bleeding, thrombosis, or heparin induced thrombocytopenia.
authors.affiliation: School of Health Professions at the University of Alabama-Birmingham, USA.
authors.forename: Margaret G
authors.initials: MG
authors.lastname: Fritsma
authors.forename: Bernadette F
authors.initials: BF
authors.lastname: Rodak
mesh_terms: D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008991:Monitoring, Physiologic; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control; D014481:United States
chemical_list: D005343:Fibrinolytic Agents